Serum alpha-fetoprotein (AFP) is the current standard of care and only approved biomarker for hepatocellular carcinoma (HCC), used for diagnosis, outcome prediction, long-term follow-up, and treatment ...
Serum AFP levels, to some extent, may correlate with prognosis. A large multicenter study of over 1000 patients with HCC recorded that 18% had a serum AFP level of greater than 400 ng/ml and that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback